• 
• http://www.nature.com/ncponc
• Editor: Vincent T. DeVita, Jr., MD
• Volume 5: 12 issues per year
• ISSN: 1743-4254
• EISSN: 1743-4262
• Impact factor : 8.217*
• Impact ranking: 7/132 in Oncology*
• Date Established: November 2004
• Published on behalf of: In collaboration with the European School of Oncology

In collaboration with the European School of Oncology

Aims and Scope:

Nature Clinical Practice Oncology is a peer-reviewed journal for oncologists and affiliated healthcare professionals.

Nature Clinical Practice Oncology delivers timely interpretations of key developments reported in original research publications, translating the latest findings into clinical pratice. Coverage includes pathology, diagnosis, treatment (e.g. chemotherapy, radiotherapy, surgery), prevention, and palliative care of all types of human malignant disease. Content is subject to rigorous peer review.

Nature Clinical Practice Oncology is published monthly in print and online. Content includes editorial and opinion pieces, highlights from the current literature, commentaries on the application of recent research to practical patient care, comprehensive reviews, and in-depth case studies.

Readership:

Oncologists, as well as other physicians with interests in cancer medicine, including hematologists, radiologists, and general surgeons. Staff and students at academic and teaching hospitals. Commercial and government organizations involved in drug development and clinical trials.

Organized into sections, content includes:

• Editorials - thoughts from the Editor-in-Chief or his nominee.
• Viewpoints - opinion articles by leading specialists, discussing topical issues in the field.
• Research Highlights - brief summaries of important articles published in the original research journals, from the specialty-specific journals to journals in other areas that may include articles with surprising relevance to the Nature Clinical Practice journal's field of coverage.
• Practice Points - unique two-page articles based on original material published elsewhere. Each Practice Point is based on a single original research paper and includes a synopsis written by our editorial team along with a commentary by a leading authority, which puts the original article into clinical context and offers expert opinion on best practice.
• Reviews - timely, authoritative reviews of key developments, written by leading specialists. In addition to general reviews, these include the following:
• Therapy Insights - leading authorities from other specialties discuss conditions and therapies that have particular relevance to the Nature Clinical Practice journal's field of coverage.
• Drug Insights - review the information physicians and trainees need to know about a drug class.
• Mechanisms of Disease - discuss the etiology of disease.
• Technology Insights - focus on advances in treatment and diagnostic technologies and equipment, such as imaging techniques and technology-assisted surgery.
• Primer Articles - provide straightforward explanations of elements essential to understanding and evaluating original clinical research. Jargon-free and aimed at non-trialists, these foundation articles cover subjects such as statistical methods and good clinical practice.
• Case Studies - fully detailed descriptions of the etiology, diagnosis, and management of individual cases.
• Continuing Medical Education - the opportunity for physicians to earn Category 1 AMA PRA credits at no additional cost.

What makes Nature Clinical Practice stand apart from other clinical review journals?

• The Nature standards of editorial excellence are applied to the series as expected by readers, authors and institutional customers.
• World-renowned experts and opinion leaders are appointed as Editors-in-Chief to ensure content focuses on the key issues in the discipline.
• A distinguished international Advisory Board ensures accurate global coverage of the specialty and related subspecialties.
• Results-focused content provides physicians with the results of clinical trials and explains their application in practice, as opposed to lengthy research details.


Editor-in-Chief: Vincent T. DeVita, Jr., MD Yale University School of Medicine
Dr. DeVita is the first appointee to the post of 'The Amy and Joseph Perella Professor of Medicine' at Yale University, in recognition of his outstanding contributions to cancer research and treatment. Dr. DeVita's past appointments include Director of the National Cancer Institute (NCI) and the National Cancer Program, Physician-in-Chief and Benno C. Schmidt Chair in Clinical Oncology at Memorial Sloan-Kettering Cancer Center, Professor of Medicine at Cornell University, Director of the Yale Cancer Center, and Chair of the National Cancer Legislative Advisory Committee. Dr. DeVita has been recognized with numerous international awards for his contributions to cancer care. These range from the 1972 Albert and Mary Lasker Medical Research Award for his contribution to the cure of Hodgkin's disease, to his election in 2002 to the European Academy of Sciences for his outstanding and ongoing contribution to cancer research and medical education. Advisory board>>

Online features and site license access:

• Online archive available back to November 2004.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content not included in the license agreement is available to purchase.
• Users have access to all the online features of nature.com. Find out more >>
• Site license customers will benefit from the services available. Find out more >>
• Indexed in Chemical Abstracts Service (CAS), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Current Contents (Clinical Medicine), EMBASE, PubMed (MEDLINE) and Science Citation Index Expanded.

*2007 Journal Citation Report (Thomson Reuters, 2008)